• 31 October 2017 - 2 November 2017 / Basel, Switzerland
     

    Discover. Develop. Bring to market.
    For biotech, pharma and their partners. 

     

     

EARLY BIRD EXPIRES IN:

Days

Hours

Minutes

Seconds

 

2017 KEYNOTE SPEAKERS INCLUDE:

 

Roy Banes

Roy Baynes
Senior Vice President & Head, Global Clinical Development, Chief Medical Officer

MSD  

Puja Sapr

Puja Sapra 
Executive Director

Pfizer Worldwide Research and Development

Michael DeRidder

Michael DeRidder
Senior Director, Early pipeline commercial strategy, Oncology, Cell Therapy

GSK

Sir Gregory Winter

Sir Gregory Winter
Master of Trintity Cambridge Universiry
Founder and co-Founder

Bicycle Therapeutics

Andre Choulika, CEO, Cellectis

André Choulika
CEO

Cellectis

Hans Klingemann

Hans G. Klingemann
Vice President, Research & Development,

NantKwest

John Delaney

John Delaney
Executive Director

Amgen Biologics Discovery
 

Andreas Plückthun
Professor of Biochemistry, Director, Department of Biochemistry

University of Zurich

VIEW THE FULL SPEAKER LIST

WHAT IS THE WORLD IMMUNOTHERAPY CONGRESS?

STRATEGIC CONFERENCE

Immunotherapy conference speakers

The congress brings together experts to discuss immune checkpoint inhibitors and cell therapy with a focus on some exciting customisations such as CAR-T and Oncolytic Viral Immunotherapy. Join us for keynotes, presentations and roundtables. 

READ MORE

SOLUTION PROVIDER EXHIBITION

Exhibit at the world immunotherapy congress

A great opportunity to debut new solutions, improve your brand awareness, meet new prospective clients and maintain existing relationships. 
 Email Derek.Cavanagh@terrapinn.com  for sponsorship information.

READ MORE

EXCELLENT NETWORKING

Network at World Immunotherapy congress

We understand the importance of networking. Meet over 400 of your peers in one room and take advantage of the multiple extended networking breaks, co-located with European Antibody Congress, World Biosimilar Congress and the HPAPI World Congress.

READ MORE

CO-LOCATED WITH

HPAPI 2017 logo

HPAPI 2017 logo

Biosimilar 2016 logo

2017 ADVISORY BOARD INCLUDES:

 

Puja Sapra

Puja Sapra
Executive Director

Pfizer

Frank Walsh

Frank Walsh
Chief Executive Officer

Ossianix

Christian Klein

Christian Klein
Head Oncology Programs

Roche

Dario Neri

Dario Neri
Founder, Professor of Chemistry and Applied Bios

Philogen, Swiss Federal Institute of Technology Zurich

Janice Reichert

Janice Reichert
Executive Director

The Antibody Society

Scott Dylla

Scott Dylla
Vice President of Research & Development Chief Scientific Officer

Abbvie Stemcentrx

Mark Chiu

Mark Chiu
Associate Director, Multispecific Biologics Engineering

Jannssen

Ulf Grawunder

Ulf Grawunder
Chief Executive Officer & Founder

NBE Therapeutics

CLICK HERE TO SEE THE FULL ADVISORY BOARD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PARTNER WITH THE WORLD IMMUNOTHERAPY CONGRESS 

 

Forge new partnerships

Generate new leads

Build your brand presence

 

DOWNLOAD PROSPECTUS

                                                        GET INVOLVED FOR 2017

immunotherapy 2016 brochure

In bringing together the key players from the immunotherapy community, this event provides an unrivalled opportunity to expose and address the current challenges facing the industry. 

Download the sponsorship prospectus to find out how this event can meet your sales and marketing objectives.

 

SPONSOR NOW

TESTIMONIALS

 

"It was a great congress with interesting speakers and cutting edge research. There was ample time for networking and a good atmosphere to promote this. Time keeping was good. Food and venue was excellent. I will be back next year!"

Head of Protein Production and Characterization   MRC Technology

"Very good speakers and interesting content."

 Global Clinical Program Leader

Novartis Institutes For BioMedical Research

 

"Interesting range and depth of talks."

 Preclinical Scientist

Cancer Research UK

 

 

"Excellent organization, interesting talks, good network opportunities."

Institute of Cell Culture and Immunotherapy

University of Stuttgart    

BOOK NOW

WHO ATTENDS

Lonza.  Adaptimmune.  Boehringer Ingelheim.  AstraZeneca.  Novartis pHarma AG.  Amal Therapeutics.  Cellectis.  Cancer Research UK.  Scancell Ltd.  MedImmune.  Mologen AG.  Axenis.  Immatics Biotechnologies GmbH.  MaxCyte, Inc.  Experimential Cancer Medicine Centres Network.  BioCanRx. Icon Plc.  Philips Research.  Actelion Pharmaceuticals Ltd.  University Hospital Basel.  Roche Pharmaceutical Research and Early Development.  Immunocore.

 

DOWNLOAD PROSPECTUS 

Sign up for event updates

 

80+ Speakers

500+ meetings

50+ Exhibitors

3   Days